emtricitabine/tenofovir disoproxil fumarate / Generic mfg. 
Welcome,         Profile    Billing    Logout  

36 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
emtricitabine/tenofovir disoproxil fumarate / Generic mfg.
2013-004809-24: The role of Home packs of HIV PEPSE in High Risk Individuals

Ongoing
4
140
Europe
Film-coated tablet, Celsentri (Trial Arm A), Truvada (Trial Arm A), Celsentri (Trial Arm B), Truvada (Trial Arm B)
Guy's & St. Thomas' NHS Foundation Trust, Viiv Healthcare UK Ltd, Gilead Sciences Ltd
HIV, HIV, Diseases [C] - Virus Diseases [C02]
 
 
2011-003447-21: Randomised controlled trial of the tolerability and completion of maraviroc compared to Kaletra© in combination with Truvada© for HIV post-exposure prophylaxis

Ongoing
4
280
Europe
Maraviroc, Celsentri, Celsentri
Camden Provider Services, Pfizer
Prophylaxis and prevention of HIV Infection.
 
 
2015-005297-37: Bone Evaluation in women over 40 who Switch from Truvada/NNRTI to Triumeq

Ongoing
4
90
Europe
Tenofovir, Lamivudine, Efavirenz, Nevirapine, Etravirine, Rilpivirine, Film-coated tablet, Tablet, Triumeq, Truvada, Atripla, Eviplera
King's College Hospital NHS Foundation Trust, ViiV Healthcare Ltd
Human Immunodeficiency Virus, People infected with Human Immunodeficiency Virus (HIV), Diseases [C] - Immune System Diseases [C20]
 
 
2014-004578-40: SSAT 066 Renal Integrase Study

Not yet recruiting
4
60
Europe
Tivicay 50 mg film - coated tablets, Isentress 400 mg Film-coated Tablets, Truvada 200 mg/245 mg film-coated tablets, Stribild 150 mg/150 mg/200 mg/245 mg film-coated tablets, Film-coated tablet, Tivicay 50 mg film-coated tablets, Isentress 400 mg Film-coated Tablets, Truvada 200 mg/245 mg film-coated tablets, Stribild 150 mg/150 mg/200 mg/245 mg film-coated tablets
St Stephen's AIDS Trust, Merck, Sharp & Dohme Limited
HIV
 
 
2017-000469-62: Pilot single‐arm clinical trial to evaluate the efficacy, PK interactions and safety of dolutegravir plus 2 NRTIs in HIV‐1‐infected solid organ transplant patients. DGT-SOT Ensayo clínico piloto de un brazo para evaluar la eficacia, las interacciones farmacocinéticas y la seguridad del dolutegravir más 2 inhibidores nucleósidos de la Transcriptasa Inversa (NRTIs en su siglas en inglés) en pacientes trasplantados de órganos sólidos infectados por el VIH-1. DGT-SOT

Ongoing
4
20
Europe
Triumeq 50 mg/600 mg/300 mg comprimidos recubiertos con película dolutegravir/abacavir/lamivudina, Tivicay 50 mg, Truvada comprimidos recubiertos con película., Coated tablet, Tablet, Triumeq®, Dolutegravir 50 mg, 200 mg de emtricitabina y 245 mg de tenofovir disoproxil (equivalente a 300 mg de tenofovir disoproxil fumarato ó 136 mg de tenofovir).
Fundació Clínic per a la Recerca Biomèdica, ViiV Healthcare
HIV-1 infected solid organ transplant patients pacientes trasplantados de órganos sólidos infectados por el VIH-1., HIV-1 infected solid organ transplant patients pacientes trasplantados de órganos sólidos infectados por el VIH-1., Diseases [C] - Virus Diseases [C02]
 
 
2017-002855-27: BonE health in ageING Women: Improvement or prevention of changes in Bone MineralDensity by Switching Antiretroviral Agents. Is there an optimal time to intervene? La salute delle ossa nell¿invecchiamento femminile: miglioramento o prevenzione delle variazioni di densit¿ minerale ossea modificando i farmaci antiretrovirali. Esiste un momento ottimale per intervenire?

Not yet recruiting
4
128
Europe
truvada, stribild, eviplera, genvoya, descovy, Odefsey, J05AR03, eviplera, J05AR18, J05AR17, J05AR19, Film-coated tablet, TRUVADA - 30 COMPRESSE RIVESTITE CON FILM IN FLACONE HDPE DA 200 MG/245 MG, STRIBILD - 150MG/150MG/200MG/245MG/ - COMPRESSA RIVESTITA CON FILM - USO ORALE - FLACONE (HDPE) - 30 COMPRESSE, EVIPLERA - 25MG RILPIVIRINA/200MG EMTRICITABINA/245MG TENOFOVIR DISOPROXIL-COMPRESSA RIVESTITA CON FILM-USO ORALE-FLACONE (HDPE) 30 COMPRESSE, GENVOYA - 150 MG / 150 MG / 200 MG /10 MG- COMPRESSA RIVESTITA CON FILM- USO ORALE- FLACONE (HDPE)- 30 COMPRESSE, DESCOVY - 200 MG/10 MG- COMPRESSA RIVESTITA CON FILM- USO ORALE- FLACONE (HDPE)- 30 COMPRESSE, ODEFSEY - 200 MG/25 MG/25 MG- COMPRESSA RIVESTITA- USO ORALE- FLACONE (HDPE) 30 COMPRESSE
UNIVERSITY HEALTH NETWORK, Gilead Sciences, Canadian HIV Trials Network
HIV infection and menopause infezione da HIV e menopausa, HIV infection and menopause infezione da HIV e menopausa, Diseases [C] - Virus Diseases [C02]
 
 
2017-004750-42: EFFICACY AND SAFETY OF A SIMPLIFICATION TREATMENT BASED ON DOLUTEGRAVIR AND DARUNAVIR / COBICISTAT VS USUAL TREATMENT IN SUPPRESSED HIV-1-INFECTED PATIENTS WITH MULTIDRUG RESISTANCE. Eficacia y seguridad de Dolutegravir más Darunavir/cobicistat como tratamiento de simplificación frente al tratamiento habitual en pacientes infectados por el VIH-1 virológicamente suprimidos y con resistencia a múltiples fármacos.

Ongoing
4
100
Europe
lamivudine, Efavirenz, Nevirapine, Film-coated tablet, Coated tablet, Capsule, hard, Tablet, Rezolsta, Tivicay, Ziagen, EMTRIVA, VIREAD, kivexa, Truvada, Intelence, Edurant, Atripla, Eviplera, Reyataz, Prezista, Kaletra, Norvir, Evotaz, Isentress, Stribild, Triumeq, Genvoya, Celsentri, Descovy
FUNDACIÓ LLUITA CONTRA LA SIDA, ViiV Healthcare
HIV-1 VIH-1, HIV infection Infección por VIH, Diseases [C] - Virus Diseases [C02]
 
 
NCT02800655: Digital Health Feedback System for Longitudinal Measurement of Medication Adherence During Anti-Retroviral (ARV)Therapy

Active, not recruiting
4
100
US
Digital Health Feedback System
University of California, San Diego, National Institute of Mental Health (NIMH), Gilead Sciences, ViiV Healthcare, GlaxoSmithKline, Proteus Digital Health, Inc.
HIV
12/21
12/23
D2ARLING, NCT04549467: Efficacy of Dolutegravir Plus Lamivudine in HIV-1-infected Treatment-naïve Adults Without a Baseline Genotyping Test

Completed
4
244
RoW
Lamivudine 300 MG, 3TC, dolutegravir, Emtricitabine / Tenofovir Disoproxil Pill, truvada
Fundacion IDEAA, ViiV Healthcare
Hiv, HIV-1-infection
09/23
09/23
DGVTAF, NCT02656511: Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection

Active, not recruiting
4
74
US
Dolutegravir, Tivicay, Emtricitabine/Tenofovir, Truvada
University of California, San Francisco, ViiV Healthcare, Gilead Sciences
HIV
05/27
05/28
2014-003419-12: Switch from Efavirenz/Atripla to Rilpivirine Switch da Efavirenz/Atripla a Rilpivirina

Ongoing
3
90
Europe
EVIPLERA, ATRIPLA, Capsule, hard, EVIPLERA, ATRIPLA
AZIENDA OSPEDALIERA SAN GERARDO, MONZA, ITALIA, Gilead Sciences Srl
HIV INFECTION INFEZIONE DA HIV, HIV HIV, Diseases [C] - Immune System Diseases [C20]
 
 
DRIVE-FORWARD, NCT02275780 / 2014-001127-69: Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)

Completed
3
769
NA
Doravirine, Darunavir, Ritonavir, TRUVADA™ or EPZICOM™/KIVEXA™
Merck Sharp & Dohme LLC
HIV-1
09/16
03/23
DISCOVER, NCT02842086 / 2016-001399-31: Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection

Active, not recruiting
3
5399
Europe, Canada, US
F/TAF, Descovy®, F/TDF, Truvada®, F/TAF Placebo, F/TDF Placebo
Gilead Sciences
Pre-Exposure Prophylaxis of HIV-1 Infection
01/19
09/27
2020-001385-11: EPICOS - Experimental clinical trial for PreventIon or COronavirus in health Care professionalS EPICOS - Ensayo para la Prevención de la Infección por COronavirus en Sanitarios

Ongoing
3
4000
Europe
Truvada, Hydroxychloroquine, Tablet, Truvada, Hydroxychloroquine
Plan Nacional Sobre SIDA, Instituto de Salud Carlos III
COVID-19 COVID-19, COVID-19 Infection (Prophylaxis) Infección COVID-19 (Profilaxis), Diseases [C] - Virus Diseases [C02]
 
 
NCT03547908 / 2018-000926-79: Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults

Completed
3
244
Europe, Japan, US, RoW
B/F/TAF, Biktarvy®, Placebo to match DTG, Placebo to match F/TDF, DTG, F/TDF, Truvada®, Placebo to match B/F/TAF
Gilead Sciences
HIV-1/HBV Co-Infection
02/22
03/24
PrEP-PP PK, NCT04937881: PK of TAF and TDF for PrEP in Pregnant and Postpartum Women

Completed
3
50
RoW
Tenofovir alafenamide, TAF, Tenofovir Disoproxil Fumarate, TDF or Truvada
University of California, Los Angeles, University of Cape Town, Desmond Tutu HIV Foundation, Gilead Sciences
Hiv
04/23
09/23
2020-001426-57: A study to compare whether giving two rather than three anti-HIV medicines daily to children and young people, aged between 2 and 15 years is assafe and effective in controlling their HIV infection Ensayo para comparar si la administración de dos en vez de tres fármacos anti-VIH diariamente en niños y pacientes jóvenes entre 2 y 15 años es tan segura y efectiva en el control de su infección por VIH.

Not yet recruiting
3
370
Europe
DTG/3TC DT, Dovato, Tivicay PD, Tivicay, Triumeq, Kivexa, Ziagen, Epivir, Combivir, Retrovir, Truvada, Descovy, Dolutegravir, Dispersible tablet, Film-coated tablet, Capsule, hard, Dovato, TIVICAY PD, TIVICAY, Triumeq, Kivexa, Ziagen, Epivir, Combivir, Retrovir, Truvada, Descovy
Fondazione Penta Onlus, ViiV Healthcare UK Limited
HIV Infection Infección por VIH, HIV Infection Infección por VIH, Diseases [C] - Virus Diseases [C02]
 
 
Impower-022, NCT04644029 / 2021-001289-39: Oral ISL QM as PrEP in Cisgender Women at High Risk for HIV-1 Infection (MK-8591-022)

Active, not recruiting
3
730
US, RoW
Islatravir, MK-8591, Placebo to FTC/TDF, FTC/TDF, TRUVADA™, Emtricitabine/Tenofovir disoproxil, Emtricitabine/Tenofovir disoproxil fumarate, Placebo to ISL
Merck Sharp & Dohme LLC
HIV-I, Human Immunodeficiency Virus Type 1, Prophylaxis
07/23
07/24
Impower-024, NCT04652700 / 2020-003309-79: Oral Islatravir (MK-8591) Once-Monthly as Preexposure Prophylaxis (PrEP) in Men and Transgender Women Who Are at High Risk for HIV-1 Infection (MK-8591-024)

Completed
3
494
Europe, Japan, US, RoW
ISL, MK-8591, FTC/TDF, Truvada, Emtricitabine/Tenofovir Disoproxil Fumarate, FTC/TAF, Descovy, Emtricitabine/Tenofovir Alafenamide, Placebo to ISL, Placebo to FTC/TDF, Placebo to FTC/TAF
Merck Sharp & Dohme LLC
HIV Preexposure Prophylaxis
08/23
08/23
AXIS, NCT06138600: Acceptability and Feasibility of Injectable Cabotegravir Pre-exposure Prophylaxis (PrEP) Versus Oral PrEP in Routine Care up to 15 Months in Private Pharmacies in South Africa

Active, not recruiting
3
200
RoW
Cabotegravir Injection [Apretude], Apretude, Tenofovir disoproxil fumarate / emtricitabine (or lamivudine), Tenemine
University of Witwatersrand, South Africa, ViiV Healthcare
HIV Infections
10/25
01/26
PrEPSteps, NCT03512418: Development of Ingestible Biosensors to Enhance PrEP Adherence in Substance Users

Completed
3
36
US
PrEPsteps, Digital pill, Truvada
Brigham and Women's Hospital, Gilead Sciences, The Fenway Institute
HIV Infections, Substance Use Disorders
04/24
04/24
SmartSteps, NCT05378399: A Context-Aware, PrEP Adherence Intervention for Individuals With Substance Use Disorder

Recruiting
3
40
US
Descovy or Truvada, ID-Cap System, digital pill, Beiwe
Brigham and Women's Hospital, Gilead Sciences, The Fenway Institute
HIV Infections, Substance Use, Adherence, Medication, Adherence, Treatment
06/24
08/24
PURPOSE 1, NCT04994509: Pre-Exposure Prophylaxis Study of Lenacapavir and Emtricitabine/Tenofovir Alafenamide in Adolescent Girls and Young Women at Risk of HIV Infection

Active, not recruiting
3
5368
RoW
Oral Lenacapavir (LEN), GS-6207, Subcutaneous (SC) Lenacapavir (LEN), F/TAF, Descovy®, F/TDF, Truvada®, Placebo SC LEN, PTM Oral LEN, PTM F/TAF, PTM F/TDF
Gilead Sciences
Pre-Exposure Prophylaxis of HIV Infection
09/24
07/27
PURPOSE 2, NCT04925752: Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection

Active, not recruiting
3
3295
US, RoW
Oral Lenacapavir (LEN), GS-6207, F/TDF, Truvada®, Sub-cutaneous (SC) Lenacapavir (LEN), Placebo SC LEN, PTM F/TDF, PTM Oral LEN, F/TAF (for US participants only)
Gilead Sciences
Pre-Exposure Prophylaxis of HIV Infection
01/25
04/27
SimpPrEP, NCT05813964: Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.

Recruiting
3
524
Europe, RoW
TDF/FTC 300mg/200mg fixed-dose combination tablets, Truvada, TAF/FTC 25mg/200mg fixed-dose combination tablets, Descovy
ANRS, Emerging Infectious Diseases, Chiang Mai University, Thailand, Ministry of Health, Thailand, Assistance Publique - Hôpitaux de Paris, FRANCE, Gilead Sciences
HIV/AIDS
10/26
05/27
HPTN 083, NCT02720094: Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men

Active, not recruiting
2/3
4570
US, RoW
Cabotegravir Oral Tablet, Oral cabotegravir, TDF/FTC tablets, Truvada, Placebo for TDF/FTC tablets, Placebo for Truvada, Placebo for cabotegravir oral tablet, Placebo for oral cabotegravir, CAB LA, Long acting cabotegravir, Injectable cabotegravir, Placebo for CAB LA, Placebo for long acting cabotegravir
National Institute of Allergy and Infectious Diseases (NIAID), ViiV Healthcare, Gilead Sciences
HIV Infections
05/20
07/24
NCT04742491: Pre-Exposure Prophylaxis for Transgender Women in the US and South America

Active, not recruiting
2/3
307
US, RoW
Immediate Intervention Arm Truvada in the US, Truvada, Deferred Intervention Arm Truvada in the US, Immediate Intervention Arm Truvada in Brazil, Deferred Intervention Arm Truvada in Brazil, Immediate Intervention Arm Descovy in the US, Descovy, Deferred Intervention Arm Descovy in the US
HIV Prevention Trials Network, Gilead Sciences
HIV Prevention
09/24
09/24
PrEPVacc, NCT04066881: A Combination Efficacy Study in Africa of Two DNA-MVA-Env Protein or DNA-Env Protein HIV-1 Vaccine Regimens With PrEP

Enrolling by invitation
2b
1668
RoW
Vaccine Group A: DNA-HIV-PT123 and AIDSVAX® B/E (weeks 0,4,24,48), Vaccine Group B: DNA-HIV-PT123 and CN54gp140+MPLA-L (weeks 0,4), then MVA and CN54gp140+MPLA-L (weeks 24,48), Vaccine Group C: Saline placebo (weeks 0,4,24,48), Control PrEP:TDF/FTC once daily (weeks 0-26), Truvada, Experimental PrEP:TAF/FTC once daily (weeks 0-26), Descovy
MRC/UVRI and LSHTM Uganda Research Unit, Imperial College London, University College, London, International AIDS Vaccine Initiative, EuroVacc Foundation, Medical Research Council, South Africa, National Institute for Medical Research, Tanzania, Muhimbili University of Health and Allied Sciences, Instituto Nacional de Saúde, Mozambique, Ludwig-Maximilians - University of Munich, King's College London, Centre Hospitalier Universitaire Vaudois, Karolinska Institutet, CONRAD, Gilead Sciences
HIV Infections
12/24
12/24
NCT03954327: Combination Antiretroviral Therapy (cART) for PBC

Completed
2
37
Canada
Emtricitabine (FTC)/Tenofovir Disoproxil (TDF), Truvada, Raltegravir, Isentress, Placebo Oral Capsule [CEBOCAP], placebo
University of Alberta, Merck Sharp & Dohme LLC
Primary Biliary Cholangitis
10/22
01/24
NCT03386578: Evaluating the Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for HIV Prevention During Pregnancy and Postpartum

Completed
2
390
RoW
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF), Truvada, Behavioral HIV risk reduction package
National Institute of Allergy and Infectious Diseases (NIAID), Gilead Sciences
HIV Infections
10/23
02/24
NCT05458765: Project Engage: Oral PrEP Acceptability

Active, not recruiting
2
330
RoW
emtricitabine/tenofovir alafenamide, Descovy, Emtricitabine / Tenofovir Disoproxil Oral Tablet, Truvada
Eastern Virginia Medical School, CONRAD, FHI 360, United States Agency for International Development (USAID), Gilead Sciences
Acceptability of Health Care, Adherence, Medication
12/23
04/24
PURPOSE 3, NCT06101329: Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)

Recruiting
2
250
US
Lenacapavir Tablet, GS-6207, Lenacapavir Injection, Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF), Truvada®
Gilead Sciences, HIV Prevention Trials Network
Pre-Exposure Prophylaxis of HIV Infection
01/28
01/28
PURPOSE-4, NCT06101342: Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103)

Recruiting
2
250
US
Lenacapavir Injection, GS-6207, Lenacapavir Tablet, Emtricitabine/tenofovir disoproxil fumarate (F/TDF), Truvada®
Gilead Sciences, HIV Prevention Trials Network, National Institute on Drug Abuse (NIDA), National Institute of Allergy and Infectious Diseases (NIAID)
Pre-Exposure Prophylaxis of HIV Infection
07/27
07/27
RTIAGS, NCT03304717: Reverse Transcriptase Inhibitors in Aicardi Goutières Syndrome

Not yet recruiting
1/2
34
US
Tenofovir (TDF) and Emtricitabine (FTC), Truvada (Tenofovir Disoproxil Fumarate and Emtricitabine), Viread (Brand for tenofovir disoproxil fumarate), Emtriva (Brand for emtricitabine), Placebo
Children's Hospital of Philadelphia, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Human Genome Research Institute (NHGRI), Gilead Sciences, Emerson Resources, National Institutes of Health (NIH)
Aicardi Goutières Syndrome
12/28
12/28
TARCoV, ChiCTR2000029468: A real-world study for lopinavir/ritonavir (LPV/r) and emtritabine (FTC) / Tenofovir alafenamide Fumarate tablets (TAF) regimen in the treatment of novel coronavirus pneumonia (COVID-19)

Not yet recruiting
N/A
120
China
Lopinavir/litonavir (LPV/r)+ emtritabine (FTC)/ Tenofovir alafenamide Fumarate tablets (TAF) in combination ;LPV/r
Institute of Emergency Medicine and Disaster Medicine Sichuan People's Hospital, Sichuan Academy of Medical Sciences; Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Department of science and technology of sichuan province (2020YFS0006)
novel coronavirus pneumonia (COVID-19)
 
 
BMS02, NCT04862975: Pharmacokinetics of Antiretroviral Drugs in Lactating Women and Breastmilk Fed Infants Under 6 Months of Age in Botswana

Recruiting
N/A
200
RoW
Dolutegravir, Dolutegravir Sodium, DTG, Lamivudine, 3TC, Emtricitabine, FTC, Tenofovir Disoproxil Fumarate, Tenofovir DF, TDF
Duke University, The Emmes Company, LLC
Lactating Women on Select DOI, Breastmilk Fed Infants of Mothers on Select DOI, HIV Infections
12/24
12/24

Download Options